Repligen Corporation (RGEN)

Exchange
NASDAQ
Symbol
RGEN
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    162.70
  • High
    165.09
  • Low
    159.79
  • Close
    159.87
  • Volume
    573,120

Financial ratios

Dec 31, 2023